Oncogenic γ-herpesviruses: Comparison of viral proteins involved in tumorigenesis

Nature Reviews Microbiology

Volumn 2, Issue 8, 2004, Pages 656-668

  Damania, Blossom ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B LYMPHOCYTE RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; BETA CATENIN; CYCLINE; CYCLOOXYGENASE 2; CYTOHESIN 1; FLICE INHIBITORY PROTEIN; G PROTEIN COUPLED RECEPTOR; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LATENT MEMBRANE PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; RANTES; STAT PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VIRUS PROTEIN;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BURKITT LYMPHOMA; CELL PROLIFERATION; COMPARATIVE STUDY; EPISOME; EPSTEIN BARR VIRUS; GENE SEQUENCE; HERPES VIRUS; HERPES VIRUS SAIMIRI; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENETIC TREE; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS GENOME; VIRUS TRANSFORMATION; ANIMAL; GENETICS; HERPES VIRUS INFECTION; METABOLISM; MOUSE; PATHOGENICITY; PATHOPHYSIOLOGY; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

ANIMALS; CELL TRANSFORMATION, VIRAL; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 2, SAIMIRIINE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; MICE; SIGNAL TRANSDUCTION; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS;

EID: 4344714976     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro958     Document Type: Review

References (160)

1. Damania, B. γ-Herpesviruses of Non-Human Primates. The Human Herpesviruses: Biology, Therapy and Immunoprophylaxis (Cambridge University Press, 2004).
2. Epstein, M. A., Achong, B. & Barr, Y. Virus particles in culture lymphoblasts from Burkitt's lymphoma. Lancet 15, 702-703 (1964).
3. Melendez, L. V., Daniel, M. D., Hunt, R. D. & Garcia, F. G. An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (Saimiri sciureus). Lab. Anim. Care 18, 374-381 (1968).
4. Chang, Y. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869 (1994).
5. Fleckenstein, B. et al. Tumour induction with DNA of oncogenic primate herpesviruses. Nature 274, 57-59 (1978).
6. Wang, D., Liebowitz, D. & Kieff, E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831-840 (1985).
7. Dawson, C. W., Rickinson, A. B. & Young, L. S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344, 777-780 (1990).
8. Kaye, K. M., Izumi, K. M. & Kieff, E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA 90, 9150-9154 (1993).
9. Uchida, J. et al. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B-lymphocyte responses. Science 286, 300-303 (1999).
10. Gires, O. et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16, 6131-6140 (1997).
11. Hatzivassiliou, E., Miller, W. E., Raab-Traub, N., Kieff, E. & Mosialos, G. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-κB, and stress-activated protein kinase. J. Immunol. 160, 1116-1121 (1998).
12. Kilger, E., Kieser, A., Baumann, M. & Hammerschmidth, W. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700-1709 (1998).
13. Huen, D. S., Henderson, S. A., Croom-Carter, D. & Rowe, M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10, 549-560 (1995).
14. Paine, E., Scheinman, R. I., Baldwin, A. S. Jr & Raab-Traub, N. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-κB/Rel family proteins. J. Virol. 69, 4572-4576 (1995).
15. Kaye, K. M. et al. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. J. Virol. 73, 10525-10530 (1999).
16. Devergne, O. et al. Role of the TRAF-binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J. Virol. 72, 7900-7908 (1998).
17. Eliopoulos, A. G., Blake, S. M., Floettmann, J. E., Rowe, M. & Young, L. S. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J. Virol. 73, 1023-1035 (1999).
18. Izumi, K. M. et al. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-κB activation. Mol. Cell. Biol. 19, 5759-5767 (1999).
19. Sandberg, M., Hammerschmidt, W. & Sugden, B. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71, 4649-4656 (1997).
20. Rothe, M., Wong, S. C., Henzel, W. J. & Goeddel, D. V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692 (1994).
21. Izumi, K. M. et al. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation. J. Virol. 73, 9908-9916 (1999).
22. Dawson, C. W., Tramountanis, G., Eliopoulos, A. G. & Young, L. S. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278, 3694-3704 (2003).
23. Eliopoulos, A. G. & Young, L. S. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16, 1731-1742 (1998).
24. Higuchi, M., Izumi, K. M. & Kieff, E. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl Acad. Sci. USA 98, 4675-4680 (2001).
25. Yasui, T., Luftig, M., Soni, V. & Kieff, E. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl Acad. Sci. USA 101, 278-283 (2004).
26. Murono, S. et al. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl Acad. Sci. USA 98, 6905-6910 (2001).
27. Wakisaka, N., Murono, S., Yoshizaki, T., Furukawa, M. & Pagano, J. S. Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res. 62, 6337-6344 (2002).
28. Yoshizaki, T., Sato, H., Furukawa, M. & Pagano, J. S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl Acad. Sci. USA 95, 3621-3626 (1998).
29. Thornburg, N. J., Pathmanathan, R. & Raab-Traub, N. Activation of nuclear factor-κB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 63, 8293-8301 (2003).
30. Miller, W. E., Cheshire, J. L., Baldwin, A. S. Jr & Raab-Traub, N. The NPC derived C15 LMP1 protein confers enhanced activation of NF-κB and induction of the EGFR in epithelial cells. Oncogene 16, 1869-1877 (1998).
31. Lee, H. et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nature Med. 4, 435-440 (1998).
32. Prakash, O. et al. Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 k1 gene. J. Natl Cancer Inst. 94, 926-935 (2002).
33. Lagunoff, M. & Ganem, D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236, 147-154 (1997).
34. Lagunoff, M., Majeti, R., Weiss, A. & Ganem, D. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Natl Acad. Sci. USA 96, 5704-5709 (1999).
35. Lee, H. et al. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol. 18, 5219-5228 (1998).
36. Tomlinson, C. C. & Damania, B. The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J. Virol. 78, 1918-1927 (2004).
37. Samaniego, F., Markham, P. D., Gallo, R. C. & Ensoli, B. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J. Immunol. 154, 3582-3592 (1995).
38. Samaniego, F., Pati, S., Karp, J., Prakash, O. & Bose, D. Human herpesvirus 8 K1-associated nuclear factor-κB-dependent promoter activity: role in Kaposi's sarcoma inflammation? J. Natl Cancer Inst. Monogr. 28, 15-23 (2001).
39. Lee, B. S., Connole, M., Tang, Z., Harris, N. L. & Jung, J. U. Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J. Virol. 77, 8072-8086 (2003).
40. Wang, L. et al. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64, 2774-2781 (2004).
41. Desrosiers, R. C. & Falk, L. A. Herpesvirus saimiri strain variability. J. Virol. 43, 352-356 (1982).
42. Duboise, S. M., Guo, J., Czajak, S., Desrosiers, R. C. & Jung, J. U. STP and TIP are essential for herpesvirus saimiri oncogenicity. J. Virol. 72, 1308-1313 (1998).
43. Murthy, S. C., Trimble, J. J. & Desrosiers, R. C. Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J. Virol. 63, 3307-3314 (1989).
44. Jung, J. U. et al. Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri. Proc. Natl Acad. Sci. USA 88, 7051-7055 (1991).
45. Choi, J. K., Ishido, S. & Jung, J. U. The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity. J. Virol. 74, 8102-8110 (2000).
46. Jung, J. U. & Desrosiers, R. C. Association of the viral oncoprotein STP-C488 with cellular Ras. Mol. Cell. Biol. 15, 6506-6512 (1995).
47. Lee, H. et al. Role of cellular tumor necrosis factor receptor-associated factors in NF-κB activation and lymphocyte transformation by herpesvirus saimiri STP. J. Virol. 73, 3913-3919 (1999).
48. Busson, P. et al. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J. Virol. 66, 3257-3262 (1992).
49. Sample, J., Liebowitz, D. & Kieff, E. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63, 933-937 (1989).
50. Fruehling, S. & Longnecker, R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251 (1997).
51. Miller, C. L., Longnecker, R. & Kieff, E. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67, 3087-3094 (1993).
52. Dykstra, M. L., Longnecker, R. & Pierce, S. K. Epstein-Barr virus co-opts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14, 57-67 (2001).
53. Miller, C. L., Lee, J. H., Kieff, E. & Longnecker, R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl Acad. Sci. USA 91, 772-776 (1994).
54. Fukuda, M. & Longnecker, R. Latent membrane protein 2A inhibits transforming growth factor-β1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 78, 1697-1705 (2004).
55. Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411 (1998).
56. Longnecker, R., Miller, C. L., Miao, X. Q., Tomkinson, B. & Kieff, E. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. J. Virol. 67, 2006-2013 (1993).
57. Scholle, F., Bendt, K. M. & Raab-Traub, N. Epstein-Barr virus LMP2A transforms epthelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74, 10681-10689 (2000).
58. Morrison, J. A., Klingelhutz, A. J. & Raab-Traub, N. Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells. J. Virol. 77, 12276-12284 (2003).
59. Glenn, M., Rainbow, L., Aurad, F., Davison, A. & Schulz, T. F. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J. Virol. 73, 6953-6963 (1999).
60. Choi, J., Lee, B. S., Shim, S., Li, M. & Jung, J. U. Identification of the novel K15 gene at the right-most end of Kaposi's sarcoma-associated herpesvirus genome. J. Virol. 74, 436-446 (2000).
61. Poole, L. J. et al. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J. Virol. 73, 6646-6660 (1999).
62. Brinkmann, M. M. et al. Activation of mitogen-activated protein kinase and NF-κB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J. Virol. 77, 9346-9358 (2003).
63. Biesinger, B. et al. The product of the herpesvirus saimiri open reading frame 1 (TIP) interacts with T-cell-specific kinase p56lck in transformed cells. J. Biol. Chem. 270, 4729-4734 (1995).
64. Jung, J. U. et al. Identification of Lck-binding elements in tip of herpesvirus saimiri. J. Biol. Chem. 270, 20660-20667 (1995).
65. Jung, J. U. et al. Downregulation of Lck-mediated signal transduction by TIP of herpesvirus saimiri. J. Virol. 69, 7814-7822 (1995).
66. Kjellen, P., Amdjadi, K., Lund, T. C., Medveczky, P. G. & Sefton, B. M. The herpesvirus saimiri TIP484 and TIP488 proteins both stimulate lck tyrosine protein kinase activity in vivo and in vitro. Virology 297, 281-288 (2002).
67. Lund, T., Medveczky, M. M. & Medveczky, P. G. Herpesvirus saimiri TIP-484 membrane protein markedly increases p56lck activity in T cells. J. Virol. 71, 378-382 (1997).
68. Guo, J. et al. Enhanced downregulation of Lck-mediated signal transduction by a Y114 mutation of herpesvirus saimiri TIP. J. Virol. 71, 7092-7096 (1997).
69. Lund, T. C., Prator, P. C., Medveczky, M. M. & Medveczky, P. G. The Lck binding domain of herpesvirus saimiri TIP-484 constitutively activates Lck and STAT3 in T cells. J. Virol. 73, 1689-1694 (1999).
70. Wehner, L. E. et al. Herpesvirus saimiri Tip gene causes T-cell lymphomas in transgenic mice. DNA Cell. Biol. 20, 81-88 (2001).
71. Wang, F., Kikutani, H., Tsang, S. F., Kishimoto, T. & Kieff, E. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 65, 4101-4106 (1991).
72. Grossman, S. R., Johannsen, E., Tong, X., Yalamanchili, R. & Kieff, E. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J κ recombination signal-binding protein. Proc. Natl Acad. Sci. USA 91, 7568-7572 (1994).
73. Kaiser, C. et al. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J. Virol. 73, 4481-4484 (1999).
74. Tong, X., Wang, F., Thut, C. J. & Kieff, E. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. J. Virol. 69, 585-588 (1995).
75. Wang, L., Grossman, S. R. & Kieff, E. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc. Natl Acad. Sci. USA 97, 430-435 (2000).
76. Rabson, M., Gradoville, L., Heston, L. & Miller, G. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol, 44, 834-844 (1982).
77. Hammerschmidt, W. & Sugden, B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397 (1989).
78. Cohen, J. I., Wang, F., Mannick, J. & Kieff, E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA 86, 9558-9562 (1989).
79. Tomkinson, B., Robertson, E. & Kieff, E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67, 2014-2025 (1993).
80. Sample, C. & Parker, B. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins. Virology 205, 534-539 (1994).
81. Tomkinson, B. & Kieff, E. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J. Virol. 66, 2893-2903 (1992).
82. Le Roux, A., Kerdiles, B., Walls, D., Dedieu, J. F. & Perricaudet, M. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205, 596-602 (1994).
83. Robertson, E. S., Lin, J. & Kieff, E. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(κ). J. Virol. 70, 3068-3074 (1996).
84. Marshall, D. & Sample, C. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69, 3624-3630 (1995).
85. Parker, G. A. et al. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13, 2541-2549 (1996).
86. Staskus, K. A. et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J. Virol. 73, 4181-4187 (1999).
87. Sadler, R. et al. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73, 5722-5730 (1999).
88. Kliche, S. et al. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol. Cell 7, 833-843 (2001).
89. Muralidhar, S. et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72, 4980-4988 (1998).
90. Muralidhar, S. et al. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J. Clin. Virol. 16, 203-213 (2000).
91. Cesarman, E. et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70, 8218-8223 (1996).
92. Guo, H. G. et al. Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology 228, 371-378 (1997).
93. Chiou, C. J. et al. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 76, 3421-3439 (2002).
94. Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C. & Cesarman, E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347-350 (1997).
95. Gershengorn, M. C., Geras-Raaka, E., Varma, A. & Clark-Lewis, I. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J. Clin. Invest. 102, 1469-1472 (1998).
96. Geras-Raaka, E., Varma, A., Clark-Lewis, I. & Gershengorn, M. C. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1α inhibit signaling by KSHV G protein-coupled receptor. Biochem. Biophys. Res. Commun. 253, 725-727 (1998).
97. Geras-Raaka, E., Varma, A., Ho, H., Clark-Lewis, I. & Gershengorn, M. C. Human interferon-γ-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Exp. Med. 188, 405-408 (1998).
98. Sodhi, A. et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor upregulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res. 60, 4873-4880 (2000).
99. Montaner, S., Sodhi, A., Pece, S., Mesri, E. A. & Gutkind, J. S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res. 61, 2641-2648 (2001).
100. Cannon, M., Philpott, N. J. & Cesarman, E. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J. Virol. 77, 57-67 (2003).
101. Bais, C. et al. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3, 131-143 (2003).
102. Bais, C. et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86-89 (1998).
103. Pati, S. et al. Activation of NF-κB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J. Virol. 75, 8660-8673 (2001).
104. Montaner, S. et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3, 23-36 (2003).
105. Yang, T. Y. et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191, 445-454 (2000).
106. Guo, H. G. et al. Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J. Virol. 77, 2631-2639 (2003).
107. Wilson, J. B., Bell, J. L. & Levine, A. J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15, 3117-3126 (1996).
108. Humme, S. et al. The EBV nuclear antigen 1 (EBNA1) enhances B-cell immortalization several thousandfold. Proc. Natl Acad. Sci. USA 100, 10989-10994 (2003).
109. Sheu, L. F. et al. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J. Pathol. 180, 243-248 (1996).
110. Tsimbouri, P., Drotar, M. E., Coy, J. L. & Wilson, J. B. bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. Oncogene 21, 5182-5187 (2002).
111. Jones, R. J. et al. Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing. Virology 313, 663-676 (2003).
112. Levitskaya, J. et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685-688 (1995).
113. Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A. & Masucci, M. G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl Acad. Sci. USA 94, 12616-12621 (1997).
114. Dittmer, D. et al. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72, 8309-8315 (1998).
115. Fakhari, F. D. & Dittmer, D. P. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative reverse transcription-PCR. J. Virol. 76 6213-6223 (2002).
116. Dittmer, D. P. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res. 63, 2010-2015 (2003).
117. Ballestas, M. E., Chatis, P. A. & Kaye, K. M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644 (1999).
118. Cotter, M. A., Subramanian, C. & Robertson, E. S. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 291, 241-259 (2001).
119. Grundhoff, A. & Ganem, D. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77, 2779-2783 (2003).
120. Garber, A. C., Hu, J. & Renne, R. LANA cooperatively binds to two sites within the terminal repeat, both sites contribute to LANA's ability to suppress transcription and facilitate DNA replication. J. Biol. Chem. 277, 27401-27411 (2002).
121. Friborg, J. Jr, Kong, W., Hottiger, M. O. & Nabel, G. J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894 (1999).
122. Radkov, S. A., Kellam, P. & Boshoff, C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nature Med. 6, 1121-1127 (2000).
123. Fujimuro, M. et al. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nature Med. 9, 300-306 (2003).
124. Hall, K. T. et al. Characterization of the herpesvirus saimiri ORF73 gene product. J. Gen. Virol. 81, 2653-2658 (2000).
125. Schafer, A. et al. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J. Virol. 77, 5911-5925 (2003).
126. Calderwood, M. A., Hall, K. T., Matthews, D. A. & Whitehouse, A. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J. Gen. Virol. 85, 147-153 (2004).
127. Verma, S. C. & Robertson, E. S. ORF73 of herpesvirus Saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats. J. Virol. 77, 12494-12506 (2003).
128. Hall, K. T. et al. The herpesvirus saimiri open reading frame 73 gene product interacts with the cellular protein p32. J. Virol. 76, 11612-11622 (2002).
129. Lan, K., Kuppers, D. A., Verma, S. C. & Robertson, E. S. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J. Virol. 78, 6585-6594 (2004).
130. Miyazaki, I., Cheung, R. K. & Dosch, H. M. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med. 178, 439-447 (1993).
131. Zeidler, R. et al. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood 90, 2390-2397 (1997).
132. de Waal Malefyt, R. et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924 (1991).
133. Salek-Ardakani, S. et al. High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin. Cytokine 17, 1-13 (2002).
134. Stuart, A. D., Stewart, J. P., Arrand, J. R. & Mackett, M. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene 11, 1711-1719 (1995).
135. Bejarano, M. T. & Masucci, M. G. Intereukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses. Blood 92, 4256-4262 (1998).
136. Suzuki, T. et al. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local energy to allogeneic and syngeneic tumors. J. Exp. Med. 182, 477-486 (1995).
137. Swaminathan, S., Hesselton, R., Sullivan, J. & Kieff, E. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J. Virol. 67, 7406-7413 (1993).
138. Moore, P. S., Boshoff, C., Weiss, R. A. & Chang, Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744 (1996).
139. Neipel, F. et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 71, 839-842 (1997).
140. Nicholas, J. et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nature Med. 3, 287-292 (1997).
141. Mori, Y. et al. Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J. Med. Virol. 61, 332-335 (2000).
142. Foussat, A. et al. Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes. Eur. Cytokine Netw. 10, 501-508 (1999).
143. Chatterjee, M., Osborne, J., Bestetti, G., Chang, Y. & Moore, P. S. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432-1435 (2002).
144. Molden, J., Chang, Y., You, Y., Moore, P. S. & Goldsmith, M. A. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272, 19625-19631 (1997).
145. Parravinci, C. et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am. J. Pathol. 151, 1517-1522 (1997).
146. Jones, K. D. et al. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94, 2871-2879 (1999).
147. Parravicini, C. et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156, 743-749 (2000).
148. Boshoff, C. et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-294 (1997).
149. H2 chemoattractant. Blood 92, 4036-4039 (1998).
150. H2 cells. Blood 95, 1151-1157 (2000).
151. Nakano, K. et al. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. Arch. Virol. 148, 871-890 (2003).
152. H2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur. J. Immunol. 31, 2458-2466 (2001).
153. Yao, Z. et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3, 811-821 (1995).
154. Yao, Z. et al. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155, 5483-5486 (1995).
155. Hollyoake, M., Stuhler, A., Farrell, P., Gordon, J. & Sinclair, A. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus. Cancer Res. 55, 4784-4787 (1995).
156. Nicholas, J., Cameron, K. R. & Honess, R. W. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 355, 362-365 (1992).
157. Ojala, P. M. et al. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nature Cell Biol. 2, 819-825 (2000).
158. Verschuren, E. W., Klefstrom, J., Evan, G. I. & Jones, N. The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2, 229-241 (2002).
159. Jung, J. U., Stager, M. & Desrosiers, R. C. Virus-encoded cyclin. Mol. Cell. Biol. 14, 7235-7244 (1994).
160. Ensser, A. et al. Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J. Exp. Med. 193, 637-642 (2001).